Omnicell, Inc.
May 20, 2009

Randall A. Lipps, Chairman, President and CEO of Omnicell, Inc., Selected to Join UCSF School of Nursing Board of Overseers

MOUNTAIN VIEW, Calif., May 20, 2009 /PRNewswire via COMTEX News Network/ -- Lipps to contribute experience in founding a technology corporation focused on improving patient safety through more efficient healthcare delivery

MOUNTAIN VIEW, Calif., May 20 /PRNewswire-FirstCall/ -- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, today announced that Randall A. Lipps, chairman, president and CEO of Omnicell, has joined the University of California, San Francisco (UCSF) School of Nursing Board of Overseers. Organized in 1987 to assist in the fulfillment of the School's mission of teaching, research, community service and patient care, the board selected Lipps for his qualifications and passion for increasing efficiency in healthcare and improving patient safety.

"The UCSF School of Nursing must anticipate and respond to changing issues and trends and must influence policies and practices in health care," said Kathleen Dracup, RN, FNP, DNSc, dean and professor, School of Nursing, University of California, San Francisco. "With his practical experience in building a technology corporation focused on improving patient safety through more efficient healthcare delivery, Randy is a valuable addition to our Board of Overseers and will help us achieve those objectives."

Lipps founded Omnicell in 1992 after watching his newborn daughter endure a traumatic health experience and has since developed the company into a technology organization focused on patient safety with over $200 million in revenue.

For the first 10 years of Omnicell's existence, Mr. Lipps served as chairman of the board of directors and guided Omnicell on a path to success. In 1998, Omnicell was recognized as the number one company in Silicon Valley in the Deloitte and Touche Technology Fast 500 program. Under Mr. Lipps' guidance and leadership, Omnicell became a publicly traded company in August of 2001.

In October 2002, Mr. Lipps assumed the additional roles of president and chief executive officer and has since provided the leadership for Omnicell's growth in providing solutions to help increase patient safety.

Prior to founding Omnicell, Mr. Lipps was an industrial engineer at American Airlines. Mr. Lipps holds bachelor's degrees in economics and business administration from Southern Methodist University.

"I am honored to be provided with the opportunity to contribute my insights and experiences to the UCSF School of Nursing," said Randall A. Lipps, chairman, president and CEO, Omnicell. "The School's national and international reputation in teaching, research, practice, and public service demonstrates excellence in the professional nursing practice."

About Omnicell

Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of systems targeting patient safety and operational efficiency in healthcare facilities. Since 1992, Omnicell has worked to enhance patient safety and allow clinicians to spend more time with their patients.

Omnicell's medication-use product line includes solutions for the central pharmacy, nursing unit, operating room, and patient bedside. Solutions range from complete automation systems for the central pharmacy to nursing unit and bedside dispensing cabinet systems. From the point at which a medication arrives at the receiving dock to the time it is administered, Omnicell systems store it, package it, bar code it, order it, issue it, and provide information and controls on its use and reorder.

Our supply product lines provide a healthcare institution with fast, effective control of costs, capture of charges for payer reimbursement, and timely reorder of supplies. Products range from high-security closed-cabinet systems and software to open-shelf and combination solutions in the nursing unit, cath lab and operating room. For more information, visit www.omnicell.com.

OMCL-G

SOURCE Omnicell, Inc.

http://www.omnicell.com

Copyright (C) 2009 PR Newswire. All rights reserved